This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Commentary

High-Dose Olanzapine for Treatment-Resistant Schizophrenia

Bryan L. Roth, MD, PhD

Published: February 14, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

In this issue of the Journal, Meltzer et al.1 presentprovocative results from a randomized, double-blind Istudy showing that larger-than-typically-prescribed dosesof olanzapine appear to be equivalent to conventionaldoses of clozapine in treatment-resistant schizophrenia.Although the sample size is relatively small (totalN = 40), the data are consistent with the notion that highdoseolanzapine might be effective in treatment-resistantschizophrenia. These findings are important because theyopen up the possibility of a new approach to treatmentresistantschizophrenia.’ ‹’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Insights

LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use

Using data from the...

Read More...